Gary Mo currently serves as the Senior Director of Global PK/PD and Pharmacometrics at Eli Lilly and Company, a position held since March 2024, after previously working as the Director of Global PK/PD and Pharmacometrics at Pfizer from April 2022 to January 2024. With extensive experience in clinical pharmacology and pharmacometrics, Gary's career includes roles as Principal Scientist I at Metrum Research Group, Senior Research Scientist, and Research Scientist at Eli Lilly. Additional experience includes a postdoctoral fellowship in PKPD modeling and simulation at both the University at Buffalo and AstraZeneca, complemented by a foundation in research as a Ph.D. student sponsored by AstraZeneca. Gary holds a Ph.D. in Neurological Sciences from McGill University and a B.Sc. in Biology and Pharmacology from McMaster University.
This person is not in any teams
This person is not in any offices